Results 11 to 20 of about 274,397 (324)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation

Heart, 2022
Objective Atrial fibrillation (AF) often progresses from paroxysmal AF (PAF) to more permanent forms. To improve personalised medicine, we aim to develop a new AF progression risk prediction model in patients with PAF.
Bao-Oanh Nguyen, Vanessa Weberndorfer, Harry JGM Crijns, Bastiaan Geelhoed, Hugo Ten Cate, Henri Spronk, Abraham Kroon, Ruben De With, Meelad Al-Jazairi, Alexander H Maass, Yuri Blaauw, Robert G Tieleman, Martin E W Hemels, Justin Luermans, Joris de Groot, Cornelis P Allaart, Arif Elvan, Mirko De Melis, Coert Scheerder, Anton Jan van Zonneveld, Ulrich Schotten, Dominik Linz, Isabelle Van Gelder, Michiel Rienstra   +23 more
openaire   +8 more sources

Paroxysmal Atrial Fibrillation Ablation Using a Novel Variable-Loop Biphasic Pulsed Field Ablation Catheter Integrated With a 3-Dimensional Mapping System: 1-Year Outcomes of the Multicenter inspIRE Study

Circulation: Arrhythmia and Electrophysiology, 2023
Background: The inspIRE study (Study for Treatment of Paroxysmal Atrial Fibrillation [PAF] by Pulsed Field Ablation [PFA] System With Irreversible Electroporation [IRE]) evaluated safety and effectiveness of a fully integrated biphasic pulsed field ...
M. Duytschaever, T. D. De Potter, M. Grimaldi, A. Anić, J. Vijgen, P. Neužil, H. Van Herendael, A. Verma, A. Skanes, D. Scherr, H. Pürerfellner, G. Račkauskas, P. Jaïs, Vivek Y. Reddy   +13 more
semanticscholar   +1 more source

Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation

Europace, 2021
Aims Treatment guidelines for patients with atrial fibrillation (AF) suggest that patients should be managed with an antiarrhythmic drug (AAD) before undergoing catheter ablation (CA).
M. Kuniss, N. Pavlović, V. Velagić, J. Hermida, Stewart Healey, G. Arena, N. Badenco, C. Meyer, Jian Chen, S. Iacopino, F. Anselme, D. Packer, H. Pitschner, C. Asmundis, S. Willems, F. Di Piazza, Daniel Becker, G. Chierchia   +17 more
semanticscholar   +1 more source

Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation

JAMA Network Open, 2021
This cohort study examines inpatient, outpatient, and pharmacy claims to identify use of antiarrhythmic drugs and catheter ablation among commercially insured adults with paroxysmal atrial fibrillation.
L. Eberly, Lohit Garg, Lin Yang, Timothy M. Markman, Ashwin S. Nathan, N. Eneanya, S. Dixit, F. Marchlinski, P. Groeneveld, D. Frankel   +9 more
semanticscholar   +1 more source

Radiofrequency Versus Cryoballoon Catheter Ablation for Paroxysmal Atrial Fibrillation: Durability of Pulmonary Vein Isolation and Effect on Atrial Fibrillation Burden

Circulation: Arrhythmia and Electrophysiology, 2021
Supplemental Digital Content is available in the text. Background: Recurrent paroxysmal atrial fibrillation (AF) after catheter ablation is presumably caused by failure to achieve durable pulmonary vein isolation (PVI).
Samuel K. Sørensen, A. Johannessen, R. Worck, M. L. Hansen, J. Hansen   +4 more
semanticscholar   +1 more source

Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance Renal denervation can reduce cardiac sympathetic activity that may result in an antiarrhythmic effect on atrial fibrillation. Objective To determine whether renal denervation when added to pulmonary vein isolation enhances long-term ...
J. Steinberg, V. Shabanov, Dmitry Ponomarev, D. Losik, Eduard Ivanickiy, E. Kropotkin, Konstantin Polyakov, P. Ptaszyński, B. Keweloh, Christopher J Yao, E. Pokushalov, A. Romanov   +11 more
semanticscholar   +1 more source

Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2020
Background The efficacy of low‐voltage‐area (LVA) ablation has not been well determined. This study aimed to investigate the efficacy of LVA ablation in addition to pulmonary vein isolation on rhythm outcomes in patients with paroxysmal atrial ...
M. Masuda, M. Asai, O. Iida, S. Okamoto, T. Ishihara, Kiyonori Nanto, T. Kanda, T. Tsujimura, Y. Matsuda, S. Okuno, Y. Hata, T. Mano   +11 more
semanticscholar   +1 more source

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation.

New England Journal of Medicine, 2016
BACKGROUND Current guidelines recommend pulmonary-vein isolation by means of catheter ablation as treatment for drug-refractory paroxysmal atrial fibrillation. Radiofrequency ablation is the most common method, and cryoballoon ablation is the second most
K. Kuck, J. Brugada, Alexander Fürnkranz, A. Metzner, F. Ouyang, K. J. Chun, Arif Elvan, T. Arentz, Kurt Bestehorn, S. Pocock, J. Albenque, Claudio Tondo   +11 more
semanticscholar   +1 more source

Pulsed field ablation of superior vena cava in paroxysmal atrial fibrillation: a case report

Frontiers in Cardiovascular Medicine, 2023
Paroxysmal atrial fibrillation originates most commonly in the pulmonary veins. However, the superior vena cava has proved to be arrhythmogenic in some cases.
Yirao Tao, Yang Zhou, Xuerong Sun, Wenkai Liao, Yanjiang Wang, Liang Shi, Xingpeng Liu   +6 more
doaj   +1 more source

Time series kernel similarities for predicting Paroxysmal Atrial Fibrillation from ECGs [PDF]

, 2018
We tackle the problem of classifying Electrocardiography (ECG) signals with the aim of predicting the onset of Paroxysmal Atrial Fibrillation (PAF).
Bianchi, Filippo Maria, Ferrante, Alberto, Livi, Lorenzo, Malek, Miroslaw, Milosevic, Jelena   +4 more
core   +3 more sources